On the Discovery of TOR As the Target of Rapamycin.
Publication
, Journal Article
Heitman, J
Published in: PLoS Pathog
2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PLoS Pathog
DOI
EISSN
1553-7374
Publication Date
2015
Volume
11
Issue
11
Start / End Page
e1005245
Location
United States
Related Subject Headings
- Virology
- Transplants
- TOR Serine-Threonine Kinases
- Sirolimus
- Immunosuppressive Agents
- Humans
- Anti-Bacterial Agents
- Animals
- 3207 Medical microbiology
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Heitman, J. (2015). On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog, 11(11), e1005245. https://doi.org/10.1371/journal.ppat.1005245
Heitman, Joseph. “On the Discovery of TOR As the Target of Rapamycin.” PLoS Pathog 11, no. 11 (2015): e1005245. https://doi.org/10.1371/journal.ppat.1005245.
Heitman J. On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog. 2015;11(11):e1005245.
Heitman, Joseph. “On the Discovery of TOR As the Target of Rapamycin.” PLoS Pathog, vol. 11, no. 11, 2015, p. e1005245. Pubmed, doi:10.1371/journal.ppat.1005245.
Heitman J. On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog. 2015;11(11):e1005245.
Published In
PLoS Pathog
DOI
EISSN
1553-7374
Publication Date
2015
Volume
11
Issue
11
Start / End Page
e1005245
Location
United States
Related Subject Headings
- Virology
- Transplants
- TOR Serine-Threonine Kinases
- Sirolimus
- Immunosuppressive Agents
- Humans
- Anti-Bacterial Agents
- Animals
- 3207 Medical microbiology
- 3204 Immunology